TABLE OF CONTENTS
1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 MARKET DEFINITION 11
1.3 OVERVIEW OF EUROPE AMNIOTIC MEMBRANE MARKET 11
1.4 LIMITATIONS 13
1.5 MARKETS COVERED 13
2 MARKET SEGMENTATION 14
2.1 MARKETS COVERED 14
2.2 GEOGRAPHICAL SCOPE 15
2.3 YEARS CONSIDERED FOR THE STUDY 15
2.4 CURRENCY AND PRICING 15
2.5 DBMR TRIPOD DATA VALIDATION MODEL 16
2.6 MULTIVARIATE MODELLING 19
2.7 PRODUCT LIFELINE CURVE 19
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 20
2.9 DBMR MARKET POSITION GRID 21
2.10 MARKET END USER COVERAGE GRID 22
2.11 VENDOR SHARE ANALYSIS 23
2.12 SECONDARY SOURCES 24
2.13 ASSUMPTIONS 24
3 EXECUTIVE SUMMARY 25
4 PREMIUM INSIGHTS 27
4.1 PESTEL ANALYSIS 28
4.2 PORTER'S FIVE FORCES MODEL 29
5 EUROPE AMNIOTIC MEMBRANE MARKET: REGULATIONS 30
5.1 REGULATIONS IN EUROPE 30
6 MARKET OVERVIEW 32
6.1 DRIVERS 34
6.1.1 RISE IN THE NUMBER OF ACCIDENTS, BURN INJURIES, AND TRAUMA CASES 34
6.1.2 INCREASE IN USE OF AMNIOTIC MEMBRANE IN OPTHALMOLOGY 34
6.1.3 BENEFITS ASSOCIATED WITH THE USE OF AMNIOTIC MEMBRANE 35
6.2 RESTRAINTS 36
6.2.1 LIMITATIONS OF AMNIOTIC MEMBRANE 36
6.2.2 STRINGENT GOVERNMENT REGULATIONS 36
6.3 OPPORTUNITIES 37
6.3.1 INCREASE IN DEMAND FOR STEM CELL RESEARCH & REGENERATIVE MEDICINE 37
6.3.2 INCREASE IN THE NUMBER OF SURGERIES 37
6.4 CHALLENGES 38
6.4.1 HIGH COST OF TREATMENT 38
6.4.2 LACK OF SKILLED PROFESSIONALS TO PERFORM AMNIOTIC MEMBRANE TRANSPLANTATION 38
6.4.3 COMPLICATIONS ASSOCIATED WITH THE USE OF AMNIOTIC MEMBRANES 39
7 IMPACT OF COVID-19 PANDEMIC ON THE MARKET 40
7.1 IMPACT ON PRICE 40
7.2 IMPACT ON DEMAND 40
7.3 IMPACT ON SUPPLY CHAIN 41
7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 41
7.5 CONCLUSION 42
8 EUROPE AMNIOTIC MEMBRANE MARKET, BY PRODUCT 43
8.1 OVERVIEW 44
8.2 DEHYDRATED AMNIOTIC MEMBRANES 47
8.3 CRYOPRESERVED AMNIOTIC MEMBRANES 47
8.4 OTHERS 48
9 EUROPE AMNIOTIC MEMBRANE MARKET, BY APPLICATION 49
9.1 OVERVIEW 50
9.2 SURGICAL WOUNDS 53
9.3 OPHTHALMOLOGY 53
9.4 OTHERS 54
10 EUROPE AMNIOTIC MEMBRANE MARKET, BY END USER 55
10.1 OVERVIEW 56
10.2 HOSPITALS 59
10.3 AMBULATORY SURGICAL CENTERS 59
10.4 RESEARCH INSTITUTES AND ACADEMIC INSTITUTES 59
10.5 SPECIALTY CLINICS 60
11 EUROPE AMNIOTIC MEMBRANE MARKET, BY COUNTRY 61
11.1 GERMANY 66
11.2 FRANCE 67
11.3 U.K. 68
11.4 ITALY 69
11.5 RUSSIA 70
11.6 SPAIN 71
11.7 SWITZERLAND 72
11.8 NETHERLANDS 73
11.9 BELGIUM 74
11.10 TURKEY 75
11.11 REST OF EUROPE 76
12 EUROPE AMNIOTIC MEMBRANE MARKET MARKET: COMPANY LANDSCAPE 77
12.1 COMPANY SHARE ANALYSIS: EUROPE 77
13 SOWT ANALYSIS 78
14 COMPANY PROFILE 79
14.1 ORGANOGENESIS, INC 79
14.1.1 COMPANY SNAPSHOT 79
14.1.2 REVENUE ANALYSIS 79
14.1.3 PRODUCT PORTFOLIO 80
14.1.4 RECENT DEVELOPMENT 80
14.2 MIMEDX 81
14.2.1 COMPANY SNAPSHOT 81
14.2.2 RECENT FINANCIALS 81
14.2.3 PRODUCT PORTFOLIO 82
14.2.4 RECENT DEVELOPMENT 82
14.3 SMITH & NEPHEW PLC 83
14.3.1 COMPANY SNAPSHOT 83
14.3.2 REVENUE ANALYSIS 83
14.3.3 PRODUCT PORTFOLIO 84
14.3.4 RECENT DEVELOPMENTS 84
14.4 AMNIO TECHNOLOGY, LLC 85
14.4.1 COMPANY SNAPSHOT 85
14.4.2 PRODUCT PORTFOLIO 85
14.4.3 RECENT DEVELOPMENTS 86
14.5 AMNIOX MEDICAL, INC. 87
14.5.1 COMPANY SNAPSHOT 87
14.5.2 PRODUCT PORTFOLIO 87
14.5.3 RECENT DEVELOPMENTS 88
14.6 AN-VISION 89
14.6.1 COMPANY SNAPSHOT 89
14.6.2 PRODUCT PORTFOLIO 89
14.6.3 RECENT DEVELOPMENTS 89
14.7 APPLIED BIOLOGICS 90
14.7.1 COMPANY SNAPSHOT 90
14.7.2 PRODUCT PORTFOLIO 90
14.7.3 RECENT DEVELOPMENTS 90
14.8 ARTHREX, INC. 91
14.8.1 COMPANY SNAPSHOT 91
14.8.2 PRODUCT PORTFOLIO 91
14.8.3 RECENT DEVELOPMENT 91
14.9 INTEGRA LIFESCIENCES 92
14.9.1 COMPANY SNAPSHOT 92
14.9.2 REVENUE ANALYSIS 92
14.9.3 PRODUCT PORTFOLIO 93
14.9.4 RECENT DEVELOPMENTS 93
14.10 KATENA PRODUCTS, INC. 94
14.10.1 COMPANY SNAPSHOT 94
14.10.2 PRODUCT PORTFOLIO 94
14.10.3 RECENT DEVELOPMENT 94
14.11 NUVISION BIOTHERAPIES LTD 95
14.11.1 COMPANY SNAPSHOT 95
14.11.2 PRODUCT PORTFOLIO 95
14.11.3 RECENT DEVELOPMENT 95
14.12 SKYE BIOLOGICS HOLDINGS, LLC 96
14.12.1 COMPANY SNAPSHOT 96
14.12.2 PRODUCT PORTFOLIO 96
14.12.3 RECENT DEVELOPMENT 96
14.13 STRYKER 97
14.13.1 COMPANY SNAPSHOT 97
14.13.2 REVENUE ANALYSIS 97
14.13.3 PRODUCT PORTFOLI0 98
14.13.4 RECENT DEVELOPMENT 98
14.14 THE ELECTROSPINNING COMPANY 99
14.14.1 COMPANY SNAPSHOT 99
14.14.2 PRODUCT PORTFOLIO 99
14.14.3 RECENT DEVELOPMENT 99
14.15 WWW.SURGILOGIX.COM 100
14.15.1 COMPANY SNAPSHOT 100
14.15.2 PRODUCT PORTFOLIO 100
14.15.3 RECENT DEVELOPMENTS 101
15 QUESTIONNAIRE 102
16 RELATED REPORTS 104

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.